3 progressive MS patients see lowered disability with CAR T-cell therapy
After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking and hand function.| Multiple Sclerosis News Today
After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking and hand function.| Multiple Sclerosis News Today
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive MS.| Multiple Sclerosis News Today
